← return to the list of all guides

Guide sequence: CCGAGTCCTTAGGCCGCCAG GGG

Contents:

Cloning and expression of guide RNA

T7 in vitro expression from a plasmid

To produce guide RNA by in vitro transcription with T7 RNA polymerase, the guide RNA sequence can be cloned into a variety of plasmids (see AddGene website).
For the guide sequence ccgagtccttaggccgccag, the following primers should be ordered for cloning into the BsaI-digested plasmid DR274 generated by the Joung lab.

NamePrimer Sequence
guideRna36rvT7sense TAGGccgagtccttaggccgccag
guideRna36rvT7antisense AAACctggcggcctaaggactcgg

T7 in vitro expression from overlapping oligonucleotides

Template for in vitro synthesis of guide RNA with T7 RNA polymerase can be prepared by annealing and primer extension of the following primers:

NamePrimer Sequence
guideRNA36rvT7crTarget GAAATTAATACGACTCACTATAGccgagtccttaggccgccagGTTTTAGAGCTAGAAATAGCAAG
guideRNAallT7common (constant primer used for all guide RNAs) AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC
T7 RNA polymerase starts transcription most efficiently if the first two nucleotides to be transcribed are GG. A common recommendation is to add the prefix GG- if our guide does not start with G (5'-N20-(NGG)-3'), to add G- if your guide starts with a single G (5'-GN19-(NGG)-3') and to not add anything if your guide starts with GG already (5'-GGN18-(NGG)-3').

One protocol for template preparation from oligonucleotides and in-vitro transcription can be found in Bassett et al. Cell Rep 2013. We also provide our own optimized protocol for T7 guide expression.

Gagnon et al. PLoS ONE 2014 prefixed guides with GG to ensure high efficiency in vitro transcription by T7 RNA polymerase. It has been shown by other authors that the 5' nucleotides of the guide have little or no role in target specificity and it is therefore generally accepted that prefixing guides with GG should not affect activity.
However, in our lab, we found that in vitro transcription with T7 RNA polymerase is efficient enough when the sequence starts with a single G rather than with GG. This took some optimization of the reaction conditions including using large amounts of template DNA and running reactions overnight. Click here to download our optimized protocol for T7 guide expression.
Do not use G-prefixing with high-fidelity Cas9 Variants like HF1 and eSpCas9 1.1 when this adds a mismatch in the genome as the efficiency will most likely be very low.

U6 expression from an Addgene plasmid

The guide sequence ccgagtccttaggccgccag does not contain the motif TTTT, which terminates RNA polymerase, so it can be transcribed in mammalian cells.

Select your Addgene plasmid:

To clone the guide into MLM3636 (Joung lab), use these primers:
Note: Efficient transcription from the U6 promoter requires a 5' G. This G has been added in the sequence below, it is underlined. For a full discussion about G- prefixing, see the discussion of G-prefixing under overlapping oligonucleotides. Do not use G- prefixing with the high-fidelity Cas9 variants HF1 and eSpCas9 1.1

NamePrimer Sequence
guideRNA36rvU6senseMLM3636 ACACCGccgagtccttaggccgccagG
guideRNA36rvU6antisenseMLM3636 AAAACctggcggcctaaggactcggCG
The plasmid has to be digested with: BsmBI
Click here to download the cloning protocol for MLM3636 (Joung lab)

Direct PCR for C. intestinalis

Only usable at the moment in Ciona intestinalis (alias Ciona robusta). DNA construct is assembled during the PCR reaction; expression cassettes are generated with One-Step Overlap PCR (OSO-PCR) Gandhi et al., Dev Bio 2016 (preprint) following this protocol. The resulting unpurified PCR product can be directly electroporated into Ciona eggs.
NamePrimer Sequence
.36rv.sgF gcgagtccttaggccgccaggtttaagagctatgctggaaacag
.36rv.U6R ctggcggcctaaggactcgcatctataccatcggatgccttc

Lentiviral vectors: cloning with Gibson assembly

Order the following oligonucleotide to clone with Gibson assembly into the vector pLentiGuide-puro. See the protocol by Matt Canver.
To clone with restriction enzymes into this vector, see the section U6 expression from an AddGene plasmid and choose pLentiGuide-puro from the list of AddGene plasmids.
If you use lentiviral vectors, you may be interested in our tools for saturating mutagenesis and for gene knockout libraries.
NameOligonucleotide Sequence
batchOligo36rv GGAAAGGACGAAACACCGccgagtccttaggccgccagGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGC

Summary of main cloning/expression primers

guideRna36rvT7sense TAGGccgagtccttaggccgccag
guideRna36rvT7antisense AAACctggcggcctaaggactcgg
guideRNA36rvT7crTarget GAAATTAATACGACTCACTATAGccgagtccttaggccgccagGTTTTAGAGCTAGAAATAGCAAG
guideRNAallT7common AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC
guideRNA36rvU6senseMLM3636 ACACCGccgagtccttaggccgccagG
guideRNA36rvU6antisenseMLM3636 AAAACctggcggcctaaggactcggCG

PCR to amplify the on-target site

Use these primers to amplify a genomic fragment around the on-target site:
OntargetGuideRna36rvLeft GAGGCTCCTGTGCAGAGAAA Tm 59.677
OntargetGuideRna36rvRight TCCGACCAGTGTTTGCCTTT Tm 60.107

Genome fragment with validation primers (underlined) and guide sequence (yellow)

Maximum amplicon length:     Primer Tm:

Genomic sequence chr7:5529726-5529749 including primers, genomic forward strand:
GAGGCTCCTGTGCAGAGAAAGCGCCCTTGCCTCCCGCCCGCTCCCGGGGCTGCCCCACCCAGCCAGCTCCCCTACCTGGT
GCCTGGGGCGCCCCACGATGGAGGGGAAGACGGCCCGGGGGGCATCGTCGCCCGCGAAGCCGGCCTTGCACATGCCGGAG
CCGTTGTCGACGACGAGCGCGGCGATATCATCATCCATGGTGAGCTGCGAGAATAGCCGGGCGCGCTGTGAGCCGAGGTC
GCCCCCGCCCTGGCCACTTCCGGCGCGCCGAGTCCTTAGGCCGCCAGGGGGCGCCGGCGCGCGCCCAGATTGGGGACAAA
GGAAGCCGGGCCGGCCGCGTTATTACCATAAAAGGCAAACACTGGTCGGA


GAGGCTCCTGTGCAGAGAAAGCGCCCTTGCCTCCCGCCCGCTCCCGGGGCTGCCCCACCCAGCCAGCTCCCCTACCTGGT
GCCTGGGGCGCCCCACGATGGAGGGGAAGACGGCCCGGGGGGCATCGTCGCCCGCGAAGCCGGCCTTGCACATGCCGGAG
CCGTTGTCGACGACGAGCGCGGCGATATCATCATCCATGGTGAGCTGCGAGAATAGCCGGGCGCGCTGTGAGCCGAGGTC
GCCCCCGCCCTGGCCACTTCCGGCGCGCCGAGTCCTTAGGCCGCCAGGGGGCGCCGGCGCGCGCCCAGATTGGGGACAAA
GGAAGCCGGGCCGGCCGCGTTATTACCATAAAAGGCAAACACTGGTCGGA

Sequence length: 369

Method: Primer3.2 with default settings, target length 250-400 bp,


Restriction Sites for PCR product validation

Cas9 induces mutations, usually 3bp 5' of the PAM site. If a mutation is induced, then it is very likely that one of the following enzymes no longer cuts your PCR product amplified from the mutant sequence. For each restriction enzyme, the guide sequence with the restriction site underlined is shown below.

EnzymePatternGuide with Restriction SiteSuppliers
NlaIV/BmiI/PspN4I/BspLIGGNNCC CCGAGTCCTTAGGCCGCCAGGGG Life Technologies, NEB, SibEnzyme, Vivantis
AcyI/BstACI/Hsp92I/BssNI/BsaHI/Hin1IGRCGYC CCGAGTCCTTAGGCCGCCAGGGG Life Technologies, NEB, Nippon Gene, Promega, SibEnzyme, Takara, Vivantis
BfoI/BstH2I/HaeIIRGCGCY CCGAGTCCTTAGGCCGCCAGGGG Life Technologies, NEB, Nippon Gene, Promega, SibEnzyme, Takara, Vivantis
HinP1I/CfoI/AspLEI/Hin6I/GlaI/BstHHI/HspAI/HhaIGCGC CCGAGTCCTTAGGCCGCCAGGGG EURx, Life Technologies, Molecular Biology Resources, NEB, Nippon Gene, Promega, Roche, SibEnzyme, Sigma, Takara, Vivantis
BseDI/BsaJI/BssECICCNNGG CCGAGTCCTTAGGCCGCCAGGGG Life Technologies, NEB, SibEnzyme
BanI/BshNI/BspT107I/AccB1IGGYRCC CCGAGTCCTTAGGCCGCCAGGGG Life Technologies, NEB, Promega, SibEnzyme, Takara, Vivantis
BstNI/MvaI/BseBI/Bst2UI/Psp6I/PspGI/AjnI/BciT130I/EcoRIICCWGG CCGAGTCCTTAGGCCGCCAGGGG Life Technologies, Minotech, NEB, Nippon Gene, Roche, SibEnzyme, Sigma, Takara, Vivantis
BslI/BseLI/Bsc4I/AfiICCNNNNNNNGG CCGAGTCCTTAGGCCGCCAGGGG Life Technologies, NEB, SibEnzyme, Vivantis
SspDI/PluTI/DinI/KasI/NarI/Mly113I/EgeI/SfoI/EheIGGCGCC CCGAGTCCTTAGGCCGCCAGGGG EURx, Life Technologies, Molecular Biology Resources, NEB, Nippon Gene, Promega, Roche, SibEnzyme, Vivantis
StyD4I/Bme1390I/BstSCI/BmrFI/ScrFI/MspR9ICCNGG CCGAGTCCTTAGGCCGCCAGGGG Life Technologies, NEB, Nippon Gene, SibEnzyme, Vivantis

All restriction enzyme sites on the amplicon sequence

Restriction sites are shown in yellow, the guide sequence is highlighted in bold. Use this schema to check if the sites are unique enough to give separate bands on a gel:

Enzyme: NlaIV/BmiI/PspN4I/BspLI, Site: GGNNCC, Restriction fragment lengths: 2bp, 69bp, 3bp, 64bp, 127bp, 75bp
GAGGCTCCTGTGCAGAGAAAGCGCCCTTGCCTCCCGCCCGCTCCCGGGGCTGCCCCACCCAGCCAGCTCCCCTACCTGGT
GCC
TGGGGCGCCCCACGATGGAGGGGAAGACGGCCCGGGGGGCATCGTCGCCCGCGAAGCCGGCCTTGCACATGCCGGAG
CC
GTTGTCGACGACGAGCGCGGCGATATCATCATCCATGGTGAGCTGCGAGAATAGCCGGGCGCGCTGTGAGCCGAGGTC
GCCCCCGCCCTGGCCACTTCCGGCGCGCCGAGTCCTTAGGCCGCCAGGGGGCGCCGGCGCGCGCCCAGATTGGGGACAAA
GGAAGCCGGGCCGGCCGCGTTATTACCATAAAAGGCAAACACTGGTCGGA

Enzyme: AcyI/BstACI/Hsp92I/BssNI/BsaHI/Hin1I, Site: GRCGYC, Restriction fragment lengths: 86bp, 197bp, 75bp
GAGGCTCCTGTGCAGAGAAAGCGCCCTTGCCTCCCGCCCGCTCCCGGGGCTGCCCCACCCAGCCAGCTCCCCTACCTGGT
GCCTGGGGCGCCCCACGATGGAGGGGAAGACGGCCCGGGGGGCATCGTCGCCCGCGAAGCCGGCCTTGCACATGCCGGAG
CCGTTGTCGACGACGAGCGCGGCGATATCATCATCCATGGTGAGCTGCGAGAATAGCCGGGCGCGCTGTGAGCCGAGGTC
GCCCCCGCCCTGGCCACTTCCGGCGCGCCGAGTCCTTAGGCCGCCAGGGGGCGCCGGCGCGCGCCCAGATTGGGGACAAA
GGAAGCCGGGCCGGCCGCGTTATTACCATAAAAGGCAAACACTGGTCGGA

Enzyme: BfoI/BstH2I/HaeII, Site: RGCGCY, Restriction fragment lengths: 19bp, 61bp, 197bp, 75bp
GAGGCTCCTGTGCAGAGAAAGCGCCCTTGCCTCCCGCCCGCTCCCGGGGCTGCCCCACCCAGCCAGCTCCCCTACCTGGT
GCCTGGGGCGCCCCACGATGGAGGGGAAGACGGCCCGGGGGGCATCGTCGCCCGCGAAGCCGGCCTTGCACATGCCGGAG
CCGTTGTCGACGACGAGCGCGGCGATATCATCATCCATGGTGAGCTGCGAGAATAGCCGGGCGCGCTGTGAGCCGAGGTC
GCCCCCGCCCTGGCCACTTCCGGCGCGCCGAGTCCTTAGGCCGCCAGGGGGCGCCGGCGCGCGCCCAGATTGGGGACAAA
GGAAGCCGGGCCGGCCGCGTTATTACCATAAAAGGCAAACACTGGTCGGA

Enzyme: HinP1I/CfoI/AspLEI/Hin6I/GlaI/BstHHI/HspAI/HhaI, Site: GCGC, Restriction fragment lengths: 20bp, 63bp, 85bp, 40bp, -2bp, 36bp, -2bp, 22bp, 2bp, -2bp, -2bp, 66bp
GAGGCTCCTGTGCAGAGAAAGCGCCCTTGCCTCCCGCCCGCTCCCGGGGCTGCCCCACCCAGCCAGCTCCCCTACCTGGT
GCCTGGGGCGCCCCACGATGGAGGGGAAGACGGCCCGGGGGGCATCGTCGCCCGCGAAGCCGGCCTTGCACATGCCGGAG
CCGTTGTCGACGACGAGCGCGGCGATATCATCATCCATGGTGAGCTGCGAGAATAGCCGGGCGCGCTGTGAGCCGAGGTC
GCCCCCGCCCTGGCCACTTCCGGCGCGCCGAGTCCTTAGGCCGCCAGGGGGCGCCGGCGCGCGCCCAGATTGGGGACAAA
GGAAGCCGGGCCGGCCGCGTTATTACCATAAAAGGCAAACACTGGTCGGA

Enzyme: BseDI/BsaJI/BssECI, Site: CCNNGG, Restriction fragment lengths: 42bp, -5bp, 32bp, 26bp, -5bp, 74bp, 32bp, 9bp, 30bp, 81bp
GAGGCTCCTGTGCAGAGAAAGCGCCCTTGCCTCCCGCCCGCTCCCGGGGCTGCCCCACCCAGCCAGCTCCCCTACCTGGT
GCCTGGGGCGCCCCACGATGGAGGGGAAGACGGCCCGGGGGGCATCGTCGCCCGCGAAGCCGGCCTTGCACATGCCGGAG
CCGTTGTCGACGACGAGCGCGGCGATATCATCATCCATGGTGAGCTGCGAGAATAGCCGGGCGCGCTGTGAGCCGAGGTC
GCCCCCGCCCTGGCCACTTCCGGCGCGCCGAGTCCTTAGGCCGCCAGGGGGCGCCGGCGCGCGCCCAGATTGGGGACAAA
GGAAGCCGGGCCGGCCGCGTTATTACCATAAAAGGCAAACACTGGTCGGA

Enzyme: BanI/BshNI/BspT107I/AccB1I, Site: GGYRCC, Restriction fragment lengths: 77bp, 3bp, 197bp, 75bp
GAGGCTCCTGTGCAGAGAAAGCGCCCTTGCCTCCCGCCCGCTCCCGGGGCTGCCCCACCCAGCCAGCTCCCCTACCTGGT
GCC
TGGGGCGCCCCACGATGGAGGGGAAGACGGCCCGGGGGGCATCGTCGCCCGCGAAGCCGGCCTTGCACATGCCGGAG
CCGTTGTCGACGACGAGCGCGGCGATATCATCATCCATGGTGAGCTGCGAGAATAGCCGGGCGCGCTGTGAGCCGAGGTC
GCCCCCGCCCTGGCCACTTCCGGCGCGCCGAGTCCTTAGGCCGCCAGGGGGCGCCGGCGCGCGCCCAGATTGGGGACAAA
GGAAGCCGGGCCGGCCGCGTTATTACCATAAAAGGCAAACACTGGTCGGA

Enzyme: BstNI/MvaI/BseBI/Bst2UI/Psp6I/PspGI/AjnI/BciT130I/EcoRII, Site: CCWGG, Restriction fragment lengths: 74bp, 2bp, 162bp, 30bp, 82bp
GAGGCTCCTGTGCAGAGAAAGCGCCCTTGCCTCCCGCCCGCTCCCGGGGCTGCCCCACCCAGCCAGCTCCCCTACCTGGT
GCCTGGGGCGCCCCACGATGGAGGGGAAGACGGCCCGGGGGGCATCGTCGCCCGCGAAGCCGGCCTTGCACATGCCGGAG
CCGTTGTCGACGACGAGCGCGGCGATATCATCATCCATGGTGAGCTGCGAGAATAGCCGGGCGCGCTGTGAGCCGAGGTC
GCCCCCGCCCTGGCCACTTCCGGCGCGCCGAGTCCTTAGGCCGCCAGGGGGCGCCGGCGCGCGCCCAGATTGGGGACAAA
GGAAGCCGGGCCGGCCGCGTTATTACCATAAAAGGCAAACACTGGTCGGA

Enzyme: BslI/BseLI/Bsc4I/AfiI, Site: CCNNNNNNNGG, Restriction fragment lengths: 36bp, -10bp, 20bp, 11bp, 141bp, 27bp, 12bp, -10bp, 55bp
GAGGCTCCTGTGCAGAGAAAGCGCCCTTGCCTCCCGCCCGCTCCCGGGGCTGCCCCACCCAGCCAGCTCCCCTACCTGGT
GCCTGGGGCGCCCCACGATGGAGGGGAAGACGGCCCGGGGGGCATCGTCGCCCGCGAAGCCGGCCTTGCACATGCCGGAG
CCGTTGTCGACGACGAGCGCGGCGATATCATCATCCATGGTGAGCTGCGAGAATAGCCGGGCGCGCTGTGAGCCGAGGTC
GCCCCCGCCCTGGCCACTTCCGGCGCGCCGAGTCCTTAGGCCGCCAGGGGGCGCCGGCGCGCGCCCAGATTGGGGACAAA
GGAAGCCGGGCCGGCCGCGTTATTACCATAAAAGGCAAACACTGGTCGGA

Enzyme: SspDI/PluTI/DinI/KasI/NarI/Mly113I/EgeI/SfoI/EheI, Site: GGCGCC, Restriction fragment lengths: 86bp, 197bp, 75bp
GAGGCTCCTGTGCAGAGAAAGCGCCCTTGCCTCCCGCCCGCTCCCGGGGCTGCCCCACCCAGCCAGCTCCCCTACCTGGT
GCCTGGGGCGCCCCACGATGGAGGGGAAGACGGCCCGGGGGGCATCGTCGCCCGCGAAGCCGGCCTTGCACATGCCGGAG
CCGTTGTCGACGACGAGCGCGGCGATATCATCATCCATGGTGAGCTGCGAGAATAGCCGGGCGCGCTGTGAGCCGAGGTC
GCCCCCGCCCTGGCCACTTCCGGCGCGCCGAGTCCTTAGGCCGCCAGGGGGCGCCGGCGCGCGCCCAGATTGGGGACAAA
GGAAGCCGGGCCGGCCGCGTTATTACCATAAAAGGCAAACACTGGTCGGA

Enzyme: StyD4I/Bme1390I/BstSCI/BmrFI/ScrFI/MspR9I, Site: CCNGG, Restriction fragment lengths: 42bp, -4bp, 26bp, 2bp, 27bp, -4bp, 97bp, 27bp, 30bp, 37bp, 40bp
GAGGCTCCTGTGCAGAGAAAGCGCCCTTGCCTCCCGCCCGCTCCCGGGGCTGCCCCACCCAGCCAGCTCCCCTACCTGGT
GCCTGGGGCGCCCCACGATGGAGGGGAAGACGGCCCGGGGGGCATCGTCGCCCGCGAAGCCGGCCTTGCACATGCCGGAG
CCGTTGTCGACGACGAGCGCGGCGATATCATCATCCATGGTGAGCTGCGAGAATAGCCGGGCGCGCTGTGAGCCGAGGTC
GCCCCCGCCCTGGCCACTTCCGGCGCGCCGAGTCCTTAGGCCGCCAGGGGGCGCCGGCGCGCGCCCAGATTGGGGACAAA
GGAAGCCGGGCCGGCCGCGTTATTACCATAAAAGGCAAACACTGGTCGGA


PCR to amplify off-target sites

Primers for all off-targets can be downloaded from the Off-target PCR page.

Saturating mutagenesis using all guides

Oligonucleotides of all guides for pooled cloning into a lentiviral vector can be downloaded from the Saturating mutagenesis page.


Version 4.7 - Documentation  - Contact us - Downloads/local installation - Paper - License
CRISPR/Cas9 Guide Designer for chordate vertebrate ecdysozoans lophotrochozoans protostomes spongi corals plants butterflies metazoans genomes fruitflies insects nematodes mammals.